Total cytosolic and nuclear extracts were prepared, as previously described [26 (link)], on saphene veins. The following primary antibodies were used: anti- IL-1β (Santa Cruz Biotechnology, Dallas, TX, USA, 1:500 #sc12742, D.B.A, Milan, Italy), anti-TNF-α (Santa Cruz Biotechnology; 1:500 #sc52746), anti-TGFβ1 (Santa Cruz Biotechnology, 1:500 #sc130348, D.B.A, Milan, Italy), anti-VEGF (Santa Cruz Biotechnology; 1:1000 #sc7269), anti- αSMA (Santa Cruz Biotechnology; 1:500 #sc53015) and anti-prolyl endopeptidase (Abcam; 1:1000,#ab58988) in 1× phosphate-buffer saline (Biogenerica srl, Catania, Italy), 5% w/v non-fat dried milk, 0.1% Tween-20 at 4 °C overnight. Membranes were incubated with peroxidase-conjugated bovine anti-mouse IgG secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA; 1:2000) for 1 h at room temperature. Anti-β-actin (Santa Cruz Biotechnology; 1:1000 #sc47778) and anti-βTubulin (Santa Cruz Biotechnology; 1:1000 #sc5274) antibodies were used as controls. Protein expression was detected by chemiluminescence (ECL) system (Thermo, Waltham, MA, USA), visualized with the ChemiDoc XRS (Bio-Rad, USA), and analyzed by using Image Lab 3.0 software (Bio-Rad, Hercules, CA, USA) as previously reported [27 (link)].
Free full text: Click here